PAPER Xi YD, Li XY, Yu HL, Jing H, Ma WW, Yuan LH, Zhang DD, Wu J, Xiao R
SEARCH RESULTS
331397 RESULTS
PAPER Niu Z, Zhao W, Zhang Z, Xiao F, Tang X, Yang J
The molecular structure of Alzheimer β-amyloid fibrils formed in the presence of phospholipid vesicles.
Angew Chem Int Ed Engl. 2014 Aug 25;53(35):9294-7. Epub 2014 May 8 PubMed: 24810551PAPER Shi L, Du X, Zhou H, Tao C, Liu Y, Meng F, Wu G, Xiong Y, Xia C, Wang Y, Bi G, Zhou JN
Cumulative effects of the ApoE genotype and gender on the synaptic proteome and oxidative stress in the mouse brain.
Int J Neuropsychopharmacol. 2014 Nov;17(11):1863-79. Epub 2014 May 9 PubMed: 24810422PAPER Huang M, Felix AR, Flood DG, Bhuvaneswaran C, Hilt D, Koenig G, Meltzer HY
The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens.
Psychopharmacology (Berl). 2014 Dec;231(23):4541-51. Epub 2014 May 9 PubMed: 24810107PAPER McCluskey LF, Geser F, Elman LB, Van Deerlin VM, Robinson JL, Lee VM, Trojanowski JQ
Atypical Alzheimer's disease in an elderly United States resident with amyotrophic lateral sclerosis and pathological tau in spinal motor neurons.
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):466-72. Epub 2014 May 9 PubMed: 24809433PAPER Deák F
Neuronal vesicular trafficking and release in age-related cognitive impairment.
J Gerontol A Biol Sci Med Sci. 2014 Nov;69(11):1325-30. Epub 2014 May 7 PubMed: 24809352PAPER
Early Alzheimer's indicator?
Johns Hopkins Med Lett Health After 50. 2014 Jan;25(13):6. PubMed: 24809125PAPER Ikezu S, Ikezu T
Tau-tubulin kinase.
Front Mol Neurosci. 2014;7:33. Epub 2014 Apr 28 PubMed: 24808823PAPER Pereira JB, Svenningsson P, Weintraub D, Brønnick K, Lebedev A, Westman E, Aarsland D
Initial cognitive decline is associated with cortical thinning in early Parkinson disease.
Neurology. 2014 Jun 3;82(22):2017-25. Epub 2014 May 7 PubMed: 24808018PAPER Kamat PK, Kalani A, Kyles P, Tyagi SC, Tyagi N
Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.
Cell Biochem Biophys. 2014 Nov;70(2):707-19. PubMed: 24807843PAPER Corace G, Angeloni C, Malaguti M, Hrelia S, Stein PC, Brandl M, Gotti R, Luppi B
Multifunctional liposomes for nasal delivery of the anti-Alzheimer drug tacrine hydrochloride.
J Liposome Res. 2014 May 7; PubMed: 24807822PAPER Shinagawa S, Shigeta M
[Acetylcholinesterase inhibitors for treatment of Alzheimer's disease].
Brain Nerve. 2014 May;66(5):507-16. PubMed: 24807367PAPER Ongali B, Nicolakakis N, Tong XK, Aboulkassim T, Papadopoulos P, Rosa-Neto P, Lecrux C, Imboden H, Hamel E
Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model.
Neurobiol Dis. 2014 Aug;68:126-36. Epub 2014 May 5 PubMed: 24807206PAPER Lista S, Zetterberg H, Dubois B, Blennow K, Hampel H
Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments.
J Neurol. 2014 Jun;261(6):1234-43. Epub 2014 May 8 PubMed: 24807087PAPER Beauchet O, Launay CP, Allali G, Annweiler C
Changes in gait variability with anti-dementia drugs: a systematic review and meta-analysis.
CNS Drugs. 2014 Jun;28(6):513-8. PubMed: 24806974Current Filters
No filters selected